Biosyent investor
WebBioSyent is continuously is looking to source pharmaceutical products that have been successfully developed and proven to be safe and effective. BioSyent then … WebMar 9, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are …
Biosyent investor
Did you know?
WebOct 28, 2013 · BioSyent only has 13.5 million shares outstanding (14.5m FD), 43% controlled by the management and the board. BioSyent's CEO Rene Goehrum owns 18% of the company, and CFO Alfred D'Souza owns 11%. Mr.
WebMar 31, 2024 · For further information please contact: Mr. René C. Goehrum President and CEO BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and … WebApr 26, 2024 · MISSISSAUGA, Ontario, April 26, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2024 Bloom Burton & Co ...
WebMar 19, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. TRENDING. Yahoo TV 'Succession' storylines reportedly inspired by Fox News owner Rupert Murdoch's family. WebBioSyent Inc. Listed on the TSX Venture Exchange (TSXV: RX) BioSyent is a profitable growth oriented speciality pharmaceutical company which searches the globe to in …
WebMar 21, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be …
WebApr 26, 2024 · MISSISSAUGA, Ontario, April 26, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at … fl workmans comp lawsWebSep 14, 2024 · René Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent’s business and corporate activities. The MicroCap Leadership Summit is attended by retail and ... greenhills shopping mallWebJun 11, 2024 · A copy of the early warning report will be available under BioSyent’s profile on SEDAR at www.sedar.com, or may be obtained by contacting Ryan Caughey, General Counsel and Corporate Secretary at ... fl work permitWebFeb 24, 2024 · 1.3% of BioSyent shares are held by institutional investors. 40.6% of BioSyent shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. greenhills slot car buildingsWebMar 24, 2024 · Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product ... flworks.orgWebNov 15, 2012 · TORONTO, ONTARIO--(Marketwire - Nov 15, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Third Quarter (Q3) 2012 financial results. - Q3 2012 Sales of $1,575,598 sets an all time quarterly record and grew by 60% over Q3 2011 green hills show lowhttp://www.biosyent.com/rx/investor_center/ green hills show low az